Mark W. Geraci

Intensive Care Medicine
3459 5th Avenue
Pittsburgh, PA 15213

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis.

Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis.

Journal: Oncotarget
Published: May 20, 2025

Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.

Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.

Journal: Circulation
Published: April 07, 2025

Cigarette Smoke and Decreased DNA Repair by Xeroderma Pigmentosum Group C Use a Double Hit Mechanism for Epithelial Cell Lung Carcinogenesis.

Cigarette Smoke and Decreased DNA Repair by Xeroderma Pigmentosum Group C Use a Double Hit Mechanism for Epithelial Cell Lung Carcinogenesis.

Journal: bioRxiv : the preprint server for biology
Published: March 10, 2025

Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials.

Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials.

Journal: NEJM evidence
Published: October 22, 2024

Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.

Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.

Journal: Circulation
Published: August 21, 2024

Business of Medicine: Developing Leaders in Academic Medicine and Learning Health Systems.

Business of Medicine: Developing Leaders in Academic Medicine and Learning Health Systems.

Journal: Journal of healthcare leadership
Published: March 16, 2024

Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial.

Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial.

Journal: The lancet. Diabetes & endocrinology
Published: November 04, 2023

Diversity supplements: An underutilized opportunity to improve the diversity of the health sciences research workforce.

Diversity supplements: An underutilized opportunity to improve the diversity of the health sciences research workforce.

Journal: Journal of clinical and translational science
Published: October 20, 2023

Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial.

Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial.

Journal: Circulation
Published: June 25, 2023

Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.

Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.

Journal: JAMA network open
Published: May 25, 2023

Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization.

Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization.

Journal: Annals of internal medicine
Published: March 20, 2023

Integrative Multiomics to Dissect the Lung Transcriptional Landscape of Pulmonary Arterial Hypertension.

Integrative Multiomics to Dissect the Lung Transcriptional Landscape of Pulmonary Arterial Hypertension.

Journal: bioRxiv : the preprint server for biology
Published: January 30, 2023
Showing 1-12 of 63

Last Updated: 09/26/2026